Mechanism of Cisplatin-Induced Cytotoxicity Is Correlated to Impaired Metabolism Due to Mitochondrial ROS Generation

The chemotherapeutic use of cisplatin is limited by its severe side effects. In this study, by conducting different omics data analyses, we demonstrated that cisplatin induces cell death in a proximal tubular cell line by suppressing glycolysis- and tricarboxylic acid (TCA)/mitochondria-related genes. Furthermore, analysis of the urine from cisplatin-treated rats revealed the lower expression levels of enzymes involved in glycolysis, TCA cycle, and genes related to mitochondrial stability and confirmed the cisplatin-related metabolic abnormalities. Additionally, an increase in the level of p53, which directly inhibits glycolysis, has been observed. Inhibition of p53 restored glycolysis and significantly reduced the rate of cell death at 24 h and 48 h due to p53 inhibition. The foremost reason of cisplatin-related cytotoxicity has been correlated to the generation of mitochondrial reactive oxygen species (ROS) that influence multiple pathways. Abnormalities in these pathways resulted in the collapse of mitochondrial energy production, which in turn sensitized the cells to death. The quenching of ROS led to the amelioration of the affected pathways. Considering these observations, it can be concluded that there is a significant correlation between cisplatin and metabolic dysfunctions involving mROS as the major player.

[1]  P. Ježek,et al.  Mitochondria in homeostasis of reactive oxygen species in cell, tissues, and organism. , 2005, The international journal of biochemistry & cell biology.

[2]  B. Kemp,et al.  Dealing with energy demand: the AMP-activated protein kinase. , 1999, Trends in biochemical sciences.

[3]  Brad T. Sherman,et al.  DAVID: Database for Annotation, Visualization, and Integrated Discovery , 2003, Genome Biology.

[4]  C. Michiels,et al.  Reciprocal influence of the p53 and the hypoxic pathways , 2011, Cell Death and Disease.

[5]  E. Neuwelt,et al.  Erratum: "The chemoprotective agent N-acetylcysteine blocks cisplatin-induced apoptosis through caspase signaling pathway" Journal of Pharmacology and Experimental Therapeutics (2005) 312 (424-431) , 2006 .

[6]  E. Neuwelt,et al.  The Chemoprotective Agent N-Acetylcysteine Blocks Cisplatin-Induced Apoptosis through Caspase Signaling Pathway , 2005, Journal of Pharmacology and Experimental Therapeutics.

[7]  E. Gottlieb,et al.  p53 regulation of metabolic pathways. , 2010, Cold Spring Harbor perspectives in biology.

[8]  Mark Ellisman,et al.  Loss of OPA1 disturbs cellular calcium homeostasis and sensitizes for excitotoxicity , 2012, Cell Death and Differentiation.

[9]  Lin Sun,et al.  Mitochondrial dynamics: regulatory mechanisms and emerging role in renal pathophysiology , 2012, Kidney international.

[10]  A. Dombkowski,et al.  The initiative role of XPC protein in cisplatin DNA damaging treatment-mediated cell cycle regulation. , 2004, Nucleic acids research.

[11]  J. Seidman,et al.  Constitutively active AMP kinase mutations cause glycogen storage disease mimicking hypertrophic cardiomyopathy. , 2002, The Journal of clinical investigation.

[12]  Channy Park,et al.  Roles of NADPH Oxidases in Cisplatin-Induced Reactive Oxygen Species Generation and Ototoxicity , 2010, The Journal of Neuroscience.

[13]  G. J. Blomquist,et al.  Comparative aspects of propionate metabolism. , 1989, Comparative biochemistry and physiology. B, Comparative biochemistry.

[14]  L. Moyec,et al.  Preferential Energy- and Potential-Dependent Accumulation of Cisplatin–Gutathione Complexes in Human Cancer Cell Lines (GLC4 and K562): A Likely Role of Mitochondria , 2006, Journal of bioenergetics and biomembranes.

[15]  B. Liu,et al.  ROS and p53: a versatile partnership. , 2008, Free radical biology & medicine.

[16]  M. Valko,et al.  Free radicals, metals and antioxidants in oxidative stress-induced cancer. , 2006, Chemico-biological interactions.

[17]  Kevin M. Ryan,et al.  p53 and metabolism , 2009, Nature Reviews Cancer.

[18]  L. Rybak,et al.  Application of Antioxidants and Other Agents to Prevent Cisplatin Ototoxicity , 1999, The Laryngoscope.

[19]  Christian von Mering,et al.  STITCH: interaction networks of chemicals and proteins , 2007, Nucleic Acids Res..

[20]  Brad T. Sherman,et al.  Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.

[21]  Young-sil Yoon,et al.  Complex II Defect via Down-regulation of Iron-Sulfur Subunit Induces Mitochondrial Dysfunction and Cell Cycle Delay in Iron Chelation-induced Senescence-associated Growth Arrest* , 2003, Journal of Biological Chemistry.

[22]  Xu Luo,et al.  Endonuclease G is an apoptotic DNase when released from mitochondria , 2001, Nature.

[23]  L. Gill,et al.  Flex-Hets differentially induce apoptosis in cancer over normal cells by directly targeting mitochondria , 2007, Molecular Cancer Therapeutics.

[24]  Eun-sook Kim,et al.  Ebselen attenuates cisplatin-induced ROS generation through Nrf2 activation in auditory cells , 2009, Hearing Research.

[25]  T. Jacks,et al.  p53-Dependent and -independent responses to cisplatin in mouse testicular teratocarcinoma cells. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[26]  J. Joseph,et al.  Mitochondrial‐targeted antioxidants represent a promising approach for prevention of cisplatin‐induced nephropathy , 2012, Free radical biology & medicine.

[27]  P. Thibault,et al.  Transcription Factor HIF-1 Is a Necessary Mediator of the Pasteur Effect in Mammalian Cells , 2001, Molecular and Cellular Biology.

[28]  E. Neuwelt,et al.  Rescue from enhanced alkylator-induced cell death with low molecular weight sulfur-containing chemoprotectants. , 2001, The Journal of pharmacology and experimental therapeutics.

[29]  W. Ludwig,et al.  Stress-induced activation of the p53 tumor suppressor in leukemia cells and normal lymphocytes requires mitochondrial activity and reactive oxygen species. , 2005, Blood.

[30]  G. Lenaers,et al.  Expression of the Opa1 mitochondrial protein in retinal ganglion cells: its downregulation causes aggregation of the mitochondrial network. , 2005, Investigative ophthalmology & visual science.

[31]  J. Enríquez,et al.  Cisplatin-mediated impairment of mitochondrial DNA metabolism inversely correlates with glutathione levels. , 2008, The Biochemical journal.

[32]  Gerard Cagney,et al.  Computational methods for the comparative quantification of proteins in label-free LCn-MS experiments , 2007, Briefings Bioinform..

[33]  Gary D Bader,et al.  Enrichment Map: A Network-Based Method for Gene-Set Enrichment Visualization and Interpretation , 2010, PloS one.

[34]  Ping Wang,et al.  Mitochondrial Modulation by Epigallocatechin 3-Gallate Ameliorates Cisplatin Induced Renal Injury through Decreasing Oxidative/Nitrative Stress, Inflammation and NF-kB in Mice , 2015, PloS one.

[35]  I. Chaudry,et al.  HYPOXIA-INDUCED ALTERATION OF MITOCHONDRIAL GENES IN CARDIOMYOCYTES: ROLE OF Bnip3 AND Pdk1 , 2010, Shock.

[36]  Z. Dong,et al.  Cisplatin nephrotoxicity: mechanisms and renoprotective strategies. , 2008, Kidney international.

[37]  N. Papadopoulos,et al.  An improved fluorescence assay for the determination of lymphocyte-mediated cytotoxicity using flow cytometry. , 1994, Journal of immunological methods.

[38]  Stefan Wölfl,et al.  Real-Time Monitoring of Cisplatin-Induced Cell Death , 2011, PloS one.

[39]  Y. Tsujimoto,et al.  Intracellular ATP levels determine cell death fate by apoptosis or necrosis. , 1997, Cancer research.

[40]  Lijun Xue,et al.  RRM2B Suppresses Activation of the Oxidative Stress Pathway and is Up-regulated by P53 During Senescence , 2012, Scientific Reports.

[41]  S. Cook,et al.  EndoG Links Bnip3-Induced Mitochondrial Damage and Caspase-Independent DNA Fragmentation in Ischemic Cardiomyocytes , 2011, PloS one.

[42]  Paul C. Wang,et al.  Mitaplatin increases sensitivity of tumor cells to cisplatin by inducing mitochondrial dysfunction. , 2012, Molecular pharmaceutics.

[43]  W. Dai,et al.  Reactive Oxygen Species-induced Phosphorylation of p53 on Serine 20 Is Mediated in Part by Polo-like Kinase-3* , 2001, The Journal of Biological Chemistry.

[44]  B. Brüne,et al.  p300 relieves p53-evoked transcriptional repression of hypoxia-inducible factor-1 (HIF-1). , 2004, The Biochemical journal.

[45]  Ally Perlina,et al.  Integrated pathway analysis of rat urine metabolic profiles and kidney transcriptomic profiles to elucidate the systems toxicology of model nephrotoxicants. , 2008, Chemical research in toxicology.

[46]  N. Holbrook,et al.  Cellular response to oxidative stress: Signaling for suicide and survival * , 2002, Journal of cellular physiology.

[47]  C. S. Lim,et al.  A mitochondria-localized two-photon fluorescent probe for ratiometric imaging of hydrogen peroxide in live tissue. , 2012, Chemical communications.

[48]  S. de Jong,et al.  Pro- and anti-apoptotic effects of p53 in cisplatin-treated human testicular cancer are cell context-dependent , 2012, Cell cycle.

[49]  Takeshi Kamiya,et al.  Mechanisms of Cisplatin-Induced Apoptosis and of Cisplatin Sensitivity: Potential of BIN1 to Act as a Potent Predictor of Cisplatin Sensitivity in Gastric Cancer Treatment , 2012, International journal of surgical oncology.

[50]  A. Moon,et al.  Identification of noninvasive biomarkers for nephrotoxicity using HK-2 human kidney epithelial cells. , 2014, Toxicological sciences : an official journal of the Society of Toxicology.

[51]  Roger E Bumgarner,et al.  Integrated genomic and proteomic analyses of a systematically perturbed metabolic network. , 2001, Science.

[52]  Damian Szklarczyk,et al.  STITCH 2: an interaction network database for small molecules and proteins , 2009, Nucleic Acids Res..

[53]  Eyal Gottlieb,et al.  TIGAR, a p53-Inducible Regulator of Glycolysis and Apoptosis , 2006, Cell.

[54]  Gary D Bader,et al.  Systematic Genetic Analysis with Ordered Arrays of Yeast Deletion Mutants , 2001, Science.

[55]  Sangdun Choi,et al.  Analysis of changes in gene expression and metabolic profiles induced by silica-coated magnetic nanoparticles. , 2012, ACS nano.

[56]  G. Lopaschuk,et al.  Contribution of oxidative metabolism and glycolysis to ATP production in hypertrophied hearts. , 1994, The American journal of physiology.

[57]  M. Rizzi,et al.  The crystal structure of human α‐amino‐β‐carboxymuconate‐ε‐semialdehyde decarboxylase in complex with 1,3‐dihydroxyacetonephosphate suggests a regulatory link between NAD synthesis and glycolysis , 2009, The FEBS journal.

[58]  G. Pezzoni,et al.  Reduced glutathione protects against cisplatin-induced neurotoxicity in rats. , 1993, Cancer research.

[59]  K. Resing,et al.  Comparison of Label-free Methods for Quantifying Human Proteins by Shotgun Proteomics*S , 2005, Molecular & Cellular Proteomics.

[60]  G. Schatten,et al.  The analysis of mitochondria and mitochondrial DNA in human embryonic stem cells. , 2006, Methods in molecular biology.

[61]  G. Shore,et al.  BH3-only BIK Regulates BAX,BAK-dependent Release of Ca2+ from Endoplasmic Reticulum Stores and Mitochondrial Apoptosis during Stress-induced Cell Death* , 2005, Journal of Biological Chemistry.

[62]  P. Knox,et al.  Automated analysis of the retinal vascular tree - parameterised data from healthy eyes , 2005 .

[63]  G. Gobe,et al.  Carvedilol Protects Against Apoptotic Cell Death Induced by Cisplatin in Renal Tubular Epithelial Cells , 2012, Journal of toxicology and environmental health. Part A.

[64]  Natalie I. Tasman,et al.  A guided tour of the Trans‐Proteomic Pipeline , 2010, Proteomics.

[65]  Scott R. Manson,et al.  Methylglyoxal Enhances Cisplatin-induced Cytotoxicity by Activating Protein Kinase Cδ* , 2002, The Journal of Biological Chemistry.

[66]  G. Mills,et al.  Expression of p53 in cisplatin-resistant ovarian cancer cell lines: modulation with the novel platinum analogue (1R, 2R-diaminocyclohexane)(trans-diacetato)(dichloro)-platinum(IV). , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[67]  Stefan Wirtz,et al.  Chemically induced mouse models of intestinal inflammation , 2007, Nature Protocols.

[68]  Damian Szklarczyk,et al.  STITCH 3: zooming in on protein–chemical interactions , 2011, Nucleic Acids Res..

[69]  Channy Park,et al.  Cisplatin Cytotoxicity of Auditory Cells Requires Secretions of Proinflammatory Cytokines via Activation of ERK and NF-κB , 2007, Journal of the Association for Research in Otolaryngology.

[70]  G. Filomeni,et al.  Reactive Oxygen Species Mediate p53 Activation and Apoptosis Induced by Sodium Nitroprusside in SH-SY5Y Cells , 2008, Molecular Pharmacology.

[71]  Jay Z. Parrish,et al.  CRN‐1, a Caenorhabditis elegans FEN‐1 homologue, cooperates with CPS‐6/EndoG to promote apoptotic DNA degradation , 2003, The EMBO journal.

[72]  C. Bokemeyer,et al.  Diagnosis and Treatment of Patients with Testicular Germ Cell Cancer , 1999, Drugs.

[73]  David W. Johnson,et al.  Comparative Analysis of Caspase Activation and Apoptosis in Renal Tubular Epithelial Cells and Renal Cell Carcinomas , 2005, Nephron Experimental Nephrology.

[74]  G. Dong,et al.  Effects of hydroxyl radical scavenging on cisplatin-induced p53 activation, tubular cell apoptosis and nephrotoxicity. , 2007, Biochemical pharmacology.